Literature DB >> 6432413

Progress in the characterization of gold drugs.

M C Grootveld, M T Razi, P J Sadler.   

Abstract

As used clinically, Myocrisin appears to contain largely polymeric (Autm)n, in which thiomalate (tm) sulphurs bridge between Au(I) ions, together with small amounts of a more reactive gold-bound thiomalate, and free thiomalate, as well as glycerol, unidentified yellow-products from autoclaving and phenylmercury adducts. Solganal usually contains thioglucose sulphinic acid as an impurity. Auranofin, on the other hand, has been crystallised. It is monomeric and Au(I) is almost linearly coordinated by P and S from triethylphosphine and tetraacetyl-beta-D-thioglucose, the latter adopting the chair conformation in the solid state and in solution. The major reaction of auranofin in acidic aqueous solutions appears to be hydrolysis of the sugar acetyl groups but other products arise if methanol is also present in the medium. NMR methods are used to examine in vitro the partition of auranofin between plasma and blood cells. The displacement of the thioglucose ligand and release of PEt3 from gold as OPEt3 are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6432413     DOI: 10.1007/bf03342617

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  17 in total

1.  Sodium aurothiomalate is a mixture.

Authors:  D A Harvey; W F Kean; C J Lock; D Singal
Journal:  Lancet       Date:  1983-02-26       Impact factor: 79.321

2.  Circulating thiomalate after administration of disodium aurothiomalate: impurity or active metabolite?

Authors:  S R Rudge; D Perrett; A J Swannell; P L Drury
Journal:  J Rheumatol       Date:  1984-04       Impact factor: 4.666

3.  The effect of cyanide on the uptake of gold by red blood cells.

Authors:  G G Graham; T M Haavisto; H M Jones; G D Champion
Journal:  Biochem Pharmacol       Date:  1984-04-15       Impact factor: 5.858

4.  A 1H nmr study of the interaction of aurothiomalate ("Myocrisin") with human red blood cells in vitro.

Authors:  G Otiko; M T Razi; P J Sadler; A A Isab; D L Rabenstein
Journal:  J Inorg Biochem       Date:  1983-11       Impact factor: 4.155

5.  Free thiomalate in plasma and urine of patients receiving sodium aurothiomalate.

Authors:  S R Rudge; D Perrett; A J Swannell
Journal:  Ann Rheum Dis       Date:  1984-02       Impact factor: 19.103

6.  Pharmacokinetics of auranofin in animals.

Authors:  A P Intoccia; T L Flanagan; D T Walz; L Gutzait; J E Swagzdis; J Flagiello; B Y Hwang; R H Dewey; H Noguchi
Journal:  J Rheumatol Suppl       Date:  1982 Jul-Aug

7.  Fate of the thiomalate part after intramuscular administration of aurothiomalate in rheumatoid arthritis.

Authors:  E Jellum; E Munthe
Journal:  Ann Rheum Dis       Date:  1982-08       Impact factor: 19.103

8.  Bis(L-cysteinato)gold(I): chemical characterization and identification in renal cortical cytoplasm.

Authors:  C F Shaw; G Schmitz; H O Thompson; P Witkiewicz
Journal:  J Inorg Biochem       Date:  1979-07       Impact factor: 4.155

9.  Distribution of gold in rat blood after intravenous administration of auranofin, gold sodium thiomalate and aurothioglucose to rats.

Authors:  D T Walz; D E Griswold; M J DiMartino; E E Bumbier
Journal:  J Rheumatol       Date:  1983-02       Impact factor: 4.666

10.  Fate of the gold and the thiomalate part after intramuscular administration of aurothiomalate to mice.

Authors:  E Jellum; E Munthe; G Guldal; J Aaseth
Journal:  Ann Rheum Dis       Date:  1980-04       Impact factor: 19.103

View more
  1 in total

1.  Anticancer Activity of Self-Assembled Molecular Rectangles via Arene-Ruthenium Acceptors and a New Unsymmetrical Amide Ligand.

Authors:  Anurag Mishra; Hyunji Jung; Jeong Woo Park; Hong Kyeung Kim; Hyunuk Kim; Peter J Stang; Ki-Whan Chi
Journal:  Organometallics       Date:  2012-04-13       Impact factor: 3.876

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.